Abiraterone acetate
NDC 64980-418, Abiraterone acetate, tablet, from Rising Pharma Holdings, Inc..
- Product NDC
- 64980-418
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208371
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/64980-418 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ABIRATERONE ACETATE250 mg/1
Pharmacologic classes
Cytochrome P450 17A1 Inhibitor [EPC]; Cytochrome P450 17A1 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 64980-418-12 | 64980041812 | 120 TABLET in 1 BOTTLE (64980-418-12) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/54ae5ef9-aea5-484a-a473-863b1397e206NADAC price for package 64980041812
GET /v1/drugs/nadac/64980041812
Use it
Look up 64980-418 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/64980-418 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 64980-418. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.